MYCL pseudogene 2 (MYCLP2)

MYCL pseudogene 2 (MYCLP2) is annotated as a processed pseudogene related to the L-myc (MYCL) gene. Pseudogenes do not code for functional proteins, and MYCLP2 lacks the ability to produce a functional product. Pseudogenes can sometimes act as regulatory RNAs, but there is no evidence that MYCLP2 has a clear biological function or relevance as a therapeutic target or disease biomarker. The canonical MYCL gene (encoding L-Myc) is a member of the MYC oncogene family and is a functional transcription factor, but this pseudogene (MYCLP2) is not functionally equivalent and does not act as a receptor, enzyme, transporter, or therapeutic target. Unless new research shows a functional role, MYCLP2 should not be considered a drug target or a candidate for targeted therapy[3][1].\n\nKey points:\n- MYCLP2 is a pseudogene and is not functionally equivalent to MYCL/L-Myc.\n- There are no known drugs or mechanisms of action, nor is it linked to disease roles or biomarkers.\n- This entry is likely incorrect for therapeutic targeting purposes[3][1].

Other names

MYCLP2L-myc-2